Toft Group Completes Executive Search for Natera, Inc. (NYSE: NTRA) in San Carlos, CA

Natera

Executive search firm Toft Group has placed Dr. Sundiep K. Phanse as Senior Director, Product Management at Natera, Inc., in San Carlos, CA. Dr. Phanse joins Natera from Thermo Fisher Scientific where she served in various management roles since 2006, most recently as the Director of Product Management, TaqMan Assays. Dr. Phanse started her career as a Consultant for Bain & Company, Inc. She earned her PhD in Chemical Engineering from the University of California, Berkeley.

About Natera, Inc.

Natera is a leading genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The mission of the company is to transform the diagnosis and management of genetic disease. In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, CA, and it currently offers a host of proprietary genetic testing services primarily to OB/GYN physicians and fertility centers, as well as to genetic laboratories through its direct sales force, laboratory distribution partners, and licensees that can run tests in their own laboratories and have the data analyzed through Natera's cloud-based Constellation™ software system. Tests include the Spectrum® pre-implantation genetic test for embryo selection during IVF; the Anora® miscarriage test to understand the genetic causes of a pregnancy loss; the Horizon™ carrier screen to detect inherited mutations; and the Panorama® non-invasive prenatal test (NIPT) to screen for common chromosomal anomalies in a fetus as early as nine weeks of gestation. Each test described has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. These tests have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests.